Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc. Fundamental Analysis
Apollo Medical Holdings, Inc. (AMEH) shows weak financial fundamentals with a PE ratio of 211.29, profit margin of 0.28%, and ROE of 1.68%. The company generates $3.0B in annual revenue with strong year-over-year growth of 46.72%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze AMEH's fundamental strength across five key dimensions:
Efficiency Score
WeakAMEH struggles to generate sufficient returns from assets.
Valuation Score
ModerateAMEH shows balanced valuation metrics.
Growth Score
ModerateAMEH shows steady but slowing expansion.
Financial Health Score
ExcellentAMEH maintains a strong and stable balance sheet.
Profitability Score
ModerateAMEH maintains healthy but balanced margins.
Key Financial Metrics
Is AMEH Expensive or Cheap?
P/E Ratio
AMEH trades at 211.29 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, AMEH's PEG of -3.59 indicates potential undervaluation.
Price to Book
The market values Apollo Medical Holdings, Inc. at 2.50 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 49.88 times EBITDA. This signals the market has high growth expectations.
How Well Does AMEH Make Money?
Net Profit Margin
For every $100 in sales, Apollo Medical Holdings, Inc. keeps $0.28 as profit after all expenses.
Operating Margin
Core operations generate 1.89 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.68 in profit for every $100 of shareholder equity.
ROA
Apollo Medical Holdings, Inc. generates $0.41 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Apollo Medical Holdings, Inc. generates limited operating cash flow of $113.93M, signaling weaker underlying cash strength.
Free Cash Flow
Apollo Medical Holdings, Inc. produces free cash flow of $119.97M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $2.68 in free cash annually.
FCF Yield
AMEH converts 6.95% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
211.29
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.59
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.50
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.57
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.11
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.40
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.004
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How AMEH Stacks Against Its Sector Peers
| Metric | AMEH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 211.29 | 29.45 | Worse (Expensive) |
| ROE | 1.68% | 779.00% | Weak |
| Net Margin | 0.28% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.11 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 1.40 | 4.65 | Neutral |
| ROA | 0.41% | -19344.00% (disorted) | Weak |
AMEH outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Apollo Medical Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
164.14%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
122.47%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
0.00%
Industry Style: Defensive, Growth, Innovation
Declining